BioWorld

March 24, 2010

Doing Well by Doing Good Can and Must Stem MDR-TB: WHO

€20M Equity Deal Gives Wilex Muscle for Partnering Talks

Stimuvax Cancer Trials on Hold Due to a Case of Encephalitis

Oncothyreon Inc. said that partner Merck Serono has halted clinical trials of Stimuvax after a study patient with multiple myeloma developed inflammation of the brain. (BioWorld Today) Read More

Positive U.S. Phase IIb Trial for GW's Sativex in Cancer Pain

Appointments And Advancements

Stock Movers

Other News To Note

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for Dec. 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 11, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

US lawmakers demand that Kennedy be held accountable

BioWorld

As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...

Medline plans record-setting $5.37B IPO

BioWorld MedTech

Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...